About Us

Patient being treated at New York Cancer & Blood Specialists

Our Vision

The experience of every cancer patient is a powerful legacy. Each patient’s story has the unique potential to teach us something new about the way cancer works, and help us find more effective treatments, faster.

At Flatiron, we believe that learning from the experience of every cancer patient is an imperative — it is the key to accelerating research and continuing to improve the quality of care. What stands in the way is an overwhelming technology challenge: Much of the available, real-world clinical data is unstructured and stored across thousands of disconnected community clinics, medical centers and hospitals. It is a problem that we believe we can solve.

Carolyn Starrett, CEO, Flatiron Health

Our Story

Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every patient story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world.

Founded in 2012, Flatiron became an independent affiliate of the Roche Group in 2018. Under the new leadership of CEO Carolyn Starrett in 2021, we’ve expanded our commitment to advance research and treatment for patients around the globe. Flatiron International subsidiaries in Japan, Germany and the United Kingdom will partner with hospitals and health networks in collaborations tailored to each market’s needs and legal, regulatory and compliance requirements.

Quick facts

  • We work with >280 community cancer centers & eight major academic cancer centers across the U.S., as well as 20+ top global developers of oncology therapeutics.

  • More than 3 million patient records available for research in our network, 75% are from community practices, 25% are from academic cancer centers.

  • Our 2,500+ employees include software engineers, data scientists, biostatisticians, epidemiologists, health professionals and other experts.

  • We partner with the U.S. Food & Drug Administration, the National Comprehensive Cancer Network® and others, and we are a founding member of the RWE Alliance.

  • Insights from our real-world data have helped expand treatment alternatives for people with gastric, esophageal and breast cancer, and illuminated the impact of healthcare policy on racial disparities in time to treatment.

  • Flatiron Health was founded in 2012 and has been an independent affiliate of the Roche Group since 2018.